Close Menu

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for Quansys Biosciences' Q-Plex SARS-CoV-2 Human IgG (4 Plex) immunoassay.

The ELISA-based test is designed to detect immunoglobulin G against SARS-CoV-2 in human serum and plasma. Samples are prepared on a 96-well microplate that is arrayed with four spots in each well — for SARS-CoV-2 spike glycoprotein 1 and 2, as well as positive and negative controls — and then imaged using Quansys' Q-View Imager Pro or Q-View Imager LS instruments with its Q-View software.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.